Analytical Diagnostic Solutions, Inc.
Publicly observedMount Laurel, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Mount Laurel | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Analytical Diagnostic Solutions, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | QNDYVJB4AQG3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant10 Sept 2026Publicly observed
NIH SBIR/STTR award: A Point of Care-Device for the Determination of Blood Tyrosine (TYR) the "TYR Now"
USD 312,453.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant15 Aug 2026Publicly observed
NIH SBIR/STTR award: A Point of Care Device for Patients with Oxalurias, the Oxalate Now
USD 311,172.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2025Publicly observed
NIH SBIR/STTR award: A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now
USD 305,352.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2023Publicly observed
NIH SBIR/STTR award: A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now
USD 1,095,992.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2023Publicly observed
NIH SBIR/STTR award: A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now
USD 906,002.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.